|
Market Closed -
Nasdaq
02:30:00 14/01/2026 am IST
|
5-day change
|
1st Jan Change
|
|
55.20 USD
|
-4.35%
|
 |
-8.11%
|
-7.12%
|
|
13/01 |
BioMarin Pharmaceutical Names Arpit Dave Chief Digital and Information Officer
|
MT
| |
13/01 |
BioMarin Pharmaceutical Inc. Appoints Arpit Davé as Executive Vice President and Chief Digital and Information Officer
|
CI
| |
18/12 |
BioMarin Pharmaceutical Inc. Appoints Rashmi Ramchandani as Chief Accounting Officer, Effective January 19, 2026
|
CI
| |
11/11 |
Medincell Appoints Dr Grace Kim, Chief Strategy Officer, U.S. Finance, to Advance into Next Stage of US Capital Growth
|
CI
| |
14/25/14 |
GeneDx Holdings Corp. Appoints Dr. Mimi Lee as Chief Precision Medicine Officer
|
CI
| |
12/25/12 |
BioMarin Pharmaceutical Inc. Announces Resignation of Chief Accounting Officer ,Effective September 2, 2025
|
CI
| |
01/25/01 |
Biomarin Pharmaceutical announces appointment of Ian T. Clark to board of directors
|
RE
| |
01/25/01 |
BioMarin Pharmaceutical Inc. Announces Appointment of Ian T. Clark to Board of Directors, Effective August 1, 2025
|
CI
| |
07/25/07 |
Viridian Therapeutics Appoints Jeff Ajer to Its Board of Directors
|
CI
| |
25/25/25 |
BioMarin Pharmaceutical Inc. Announces Appointment of Timothy P. Walbert to Board of Directors
|
CI
| |
15/24/15 |
Biomarin Pharmaceutical Insider Sold Shares Worth $350,324, According to a Recent SEC Filing
|
MT
| |
21/24/21 |
BioMarin Pharmaceutical Inc. Announces Management Changes
|
CI
| |
31/24/31 |
BioMarin Pharmaceutical Insider Sold Shares Worth $3,043,802, According to a Recent SEC Filing
|
MT
| |
14/24/14 |
Biomarin Pharmaceutical Insider Sold Shares Worth $3,255,200, According to a Recent SEC Filing
|
MT
| |
07/24/07 |
Biomarin Pharmaceutical Insider Sold Shares Worth $414,550, According to a Recent SEC Filing
|
MT
| |
16/24/16 |
Biomarin Pharmaceutical Insider Sold Shares Worth $3,645,000, According to a Recent SEC Filing
|
MT
| |
02/24/02 |
Biomarin Pharmaceutical Insider Sold Shares Worth $2,173,341, According to a Recent SEC Filing
|
MT
| |
08/24/08 |
Biomarin Pharmaceutical Insider Sold Shares Worth $348,280, According to a Recent SEC Filing
|
MT
| |
08/24/08 |
BioMarin Pharmaceutical Appoints Cristin Hubbard as Chief Commercial Officer
|
MT
| |
07/24/07 |
Biomarin Announces Board Changes, Effective May 20, 2024
|
CI
| |
12/24/12 |
Biomarin Pharmaceutical Inc. Announces Resignation of Jeffrey Ajer as Executive Vice President and Chief Commercial Officer, Effective from July 1, 2024
|
CI
| |
12/24/12 |
Biomarin Pharmaceutical Insider Sold Shares Worth $1,945,700, According to a Recent SEC Filing
|
MT
| |
23/23/23 |
Biomarin Pharmaceutical Insider Sold Shares Worth $939,900, According to a Recent SEC Filing
|
MT
| |
21/23/21 |
BioMarin Pharmaceutical Inc. Announces Board Appointments, Effective December 27, 2023
|
CI
| |
15/23/15 |
Biomarin Pharmaceutical Insider Sold Shares Worth $1,311,709, According to a Recent SEC Filing
|
MT
|
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
